Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers O > Headlines for Oncothyreon Inc. > News item |
Oncothyreon arranges $50 million at-the-market sales agreement
Agent Cowen and Co. to conduct offering and will be paid 3% commission
By Devika Patel
Knoxville, Tenn., June 2 – Oncothyreon Inc. arranged a $50 million at-the-market sales agreement with Cowen and Co., LLC on June 2, according to an 8-K and prospectus supplement filed Thursday with the Securities and Exchange Commission.
Cowen will be paid a 3% commission.
Proceeds will be used for general corporate purposes, including research and development and possible acquisitions.
Oncothyreon is a Seattle-based biotechnology company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.